Frazier Financial Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Frazier Financial Advisors’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18K	Hold	63	–	–	0.01%	324
2026 Q1	$18.7K	Hold	63	–	–	0.01%	332
2025 Q4	$19.1K	Hold	63	–	–	0.01%	282
2025 Q3	$21.5K	Hold	63	–	–	0.01%	264
2025 Q2	$15.3K	Buy	63 +15	+31%	+$3.68K	0.01%	296
2025 Q1	$13.1K	Hold	48	–	–	0.01%	295
2024 Q4	$8.82K	Hold	48	–	–	0.01%	364
2024 Q3	$10.8K	Sell	48 -22	-31%	-$3.96K	0.01%	355
2024 Q2	$9.99K	Hold	70	–	–	0.01%	436
2024 Q1	$10.9K	Buy	70 +22	+46%	+$3.54K	0.01%	391
2023 Q4	$8.66K	Buy	+48	New	+$8.68K	0.01%	382

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Frazier Financial Advisors's ONC Position: Q2 2026 in Review

Frazier Financial Advisors held its BeOne Medicines Ltd (ONC) position steady in Q2 2026 at 63 shares worth $18K. The position accounts for 0.01% of the portfolio, ranked #324.

Frazier Financial Advisors first reported a position in ONC in Q4 2023 and has held it in 11 quarters since. The position peaked at $21.5K in Q3 2025. 283 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

Frazier Financial Advisors held 63 shares of BeOne Medicines Ltd worth $18K as of Q2 2026.
Frazier Financial Advisors left its BeOne Medicines Ltd share count unchanged in Q2 2026.
BeOne Medicines Ltd made up 0.01% of Frazier Financial Advisors's portfolio in Q2 2026, its #324 holding.
Frazier Financial Advisors first reported a position in BeOne Medicines Ltd in Q4 2023 and has held it in 11 quarters since.
Frazier Financial Advisors's BeOne Medicines Ltd position peaked at $21.5K in Q3 2025.
283 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Frazier Financial Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.